What Examedi (yc S21) does

Examedi operates a healthcare-at-home marketplace that connects patients seeking medical examinations with nurses and lab technicians who deliver those services at the patient's residence. The company's stated purpose is to remove the inconvenience of clinic visits for routine health checkups and diagnostic testing by enabling a consumer to select examinations from a catalog and schedule a home appointment. The product is presented as a single unified service, branded "At-Home Health Exams," rather than a multi-module platform, and is delivered through a direct-to-consumer flow on the company's website (examedi.us).

The underlying offering is operational rather than technological: Examedi curates and dispatches licensed clinical labor to patient homes and functions as the intermediary layer for booking, scheduling, and service delivery. No proprietary technology stack, software architecture, API surface, or AI/ML components are documented in the source material, and no integrations, SDKs, or developer-facing platform capabilities are disclosed. The company does not provide public pricing, subscription terms, or unit economics, and its revenue model is not articulated beyond the implied per-booking marketplace mechanics.

Examedi emerged from the Y Combinator Summer 2021 (S21) batch, which is the most concrete signal of its venture-backed, early-stage private status. Beyond the accelerator affiliation, no subsequent funding rounds, named investors, headcount, leadership team, geographic footprint, or partnerships are documented. The site contains Spanish-language interface elements, which may indicate a Latin American operating context, but no operating geographies, customer count, or regulatory jurisdictions are formally disclosed. As a result, while the business concept and target segment are clear, the company remains in a thinly evidenced pre-scale state.

Name

Examedi (yc S21)

Website

https://examedi.com

Company type

Private

Operating status

Operating

Short description

Examedi is a healthcare-at-home marketplace that connects patients with nurses and lab technicians to deliver medical examinations and health checkups directly at the patient's residence, targeting individual healthcare consumers.

Ownership category

akta.pro rank

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Core offering

Examedi operates an online marketplace that connects patients with nurses and lab technicians to deliver health examinations and diagnostic checkups directly at the patient's home. Users select examinations from an online catalog, schedule an appointment, and receive the medical service at their residence instead of visiting a clinic or hospital.

Product overview

Examedi offers a single unified at-home health service allowing users to book and receive medical exams and health checkups in the comfort of their homes. Users can select and add services from a catalog of examinations and proceed to schedule appointments. The product is delivered as a direct consumer-facing healthcare service rather than a multi-module platform.

Differentiator

Problem solved

Functional benefit

Products and services

• At-Home Health Exams At-home medical testing and health checkup services that allow patients to receive diagnostic examinations without visiting a clinic; users select examinations from a catalog and schedule appointments with nurses or lab technicians who visit the home.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Direct peers

• DispatchHealth: US-based on-demand urgent care service that dispatches clinicians to patients' homes for acute and post-acute care. Most directly comparable to Examedi in matching patients with mobile clinicians for at-home medical services via a marketplace model.
• Medically Home: Hospital-at-home platform that enables health systems to deliver acute and post-acute care in patients' homes via in-person and virtual clinicians. Comparable in mobilizing healthcare providers to the patient's residence through a coordinated service model.
• Ready (formerly Ready Responders): In-home urgent care service delivering clinicians to patients for non-emergency medical needs. Directly comparable as a home-visit healthcare provider network operating on a marketplace-style dispatch model.
• Heal: On-demand doctor house-call platform (acquired by Humana) that brings physicians to patients' homes via an app. Comparable as a digital marketplace routing patients to healthcare professionals for in-home care.
• Pager: Concierge-style on-demand healthcare platform that connects patients with clinicians for in-home and virtual visits. Comparable as a digital marketplace matching patient demand with a network of on-call healthcare providers.

Broad incumbents

• Docplanner: Large healthcare booking and practice management platform serving patients and providers across Latin America and Europe. Adjacent as a healthcare marketplace at materially greater scale and multi-geography footprint, with overlapping distribution dynamics.
• Amedisys (with Contessa Health): Large US home health and hospice operator that acquired Contessa Health to add hospital-at-home services. Comparable as a home-based healthcare delivery model, though embedded within a much broader post-acute care portfolio and geographic footprint.

Regional players

• Doctoralia: Doctor marketplace and booking platform operating primarily in Spain and Latin America (part of Docplanner Group). Comparable as a two-sided healthcare appointment marketplace in overlapping geographies, though focused on clinic visits rather than home visits.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Examedi (yc S21)